|
1.
|
Aubert S, Wacrenier A, Leroy X, Devos P,
Carnaille B, Proye C, Wemeau JL, Lecomte-Houcke M and Leteurtre E:
Weiss system revisited: A clinicopathologic and immunohistochemical
study of 49 adrenocortical tumors. Am J Surg Pathol. 26:1612–1619.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Roman S: Adrenocortical carcinoma. Curr
Opin Oncol. 18:36–42. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Fassnacht M and Allolio B: Clinical
management of adrenocortical carcinoma. Best Pract Res Clin
Endocrinol Metab. 23:273–289. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Ng L and Libertino JM: Adrenocortical
carcinoma: Diagnosis, evaluation and treatment. J Urol. 169:5–11.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Ekici S and Ciancio G: Surgical management
of large adrenal masses with or without thrombus extending into the
inferior vena cava. J Urol. 172:2340–2343. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Hoffman DL and Mattox VR: Treatment of
adrenal cortical carcinoma with o,p'-DDD. Med Clin North Am.
56:999–1012. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Luton JP, Cerdas S, Billaud L, Thomas G,
Guilhaume B, Bertagna X, Laudat MH, Louvel A, Chapuis Y and
Blondeau P: Clinical features of adrenocortical carcinoma,
prognostic factors, and the effect of mitotane therapy. N Engl J
Med. 322:1195–1201. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Nardi P, Pellegrino A, Pugliese M, Bovio
E, Chiariello L and Ruvolo G: Cardiac surgery with extracorporeal
circulation and concomitant malignancy: Early and long-term
results. J Cardiovasc Med (Hagerstown). 17:152–159. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Bertherat J, Coste J and Bertagna X:
Adjuvant mitotane in adrenocortical carcinoma. N Engl J Med.
357:1256–1257. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Kerkhofs TM, Verhoeven RH, Van der Zwan
JM, Dieleman J, Kerstens MN, Links TP, Van de Poll-Franse LV and
Haak HR: Adrenocortical carcinoma: A population-based study on
incidence and survival in the Netherlands since 1993. Eur J Cancer.
49:2579–2586. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Kebebew E, Reiff E, Duh QY, Clark OH and
McMillan A: Extent of disease at presentation and outcome for
adrenocortical carcinoma: Have we made progress? World J Surg.
30:872–878. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Puvaneswary M and Thong K: Primary
hyperaldosteronism: Due to adrenal cortical carcinoma. Australas
Radiol. 37:88–89. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Coonrod DV and Rizkallah TH: Virilizing
adrenal carcinoma in a woman of reproductive age: A case
presentation and literature review. Am J Obstet Gynecol.
172:1912–1915. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Lanigan D, Choa RG and Evans J: A
feminizing adrenocortical carcinoma presenting with gynaecomastia.
Postgrad Med J. 69:481–483. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Chiche L, Dousset B, Kieffer E and Chapuis
Y: Adrenocortical carcinoma extending into the inferior vena cava:
Presentation of a 15-patient series and review of the literature.
Surgery. 139:15–27. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Tritos NA, Cushing GW, Heatley G and
Libertino JA: Clinical features and prognostic factors associated
with adrenocortical carcinoma: Lahey Clinic Medical Center
experience. Am Surg. 66:73–79. 2000.PubMed/NCBI
|
|
17.
|
Bodie B, Novick AC, Pontes JE, Straffon
RA, Montie JE, Babiak T, Sheeler L and Schumacher P: The Cleveland
Clinic experience with adrenal cortical carcinoma. J Urol.
141:257–260. 1989.PubMed/NCBI
|
|
18.
|
Hedican SP and Marshall FF: Adrenocortical
carcinoma with intracaval extension. J Urol. 158:2056–2061. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Lebastchi AH, Kunstman JW and Carling T:
Adrenocortical carcinoma: Current therapeutic state-of-the-art. J
Oncol. 2012:2347262012. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Allolio B, Hahner S, Weismann D and
Fassnacht M: Management of adrenocortical carcinoma. Clin
Endocrinol (Oxf). 60:273–287. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Dackiw AP, Lee JE, Gagel RF and Evans DB:
Adrenal cortical carcinoma. World J Surg. 25:914–926. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Ochi T, Tanji N, Shimamoto K, Ikeda T,
Toshino A and Yokoyama M: Application of cardiopulmonary bypass for
resection of renal cell carcinoma and adrenocortical carcinoma
extending into the right atrium. Int J Urol. 13:202–205. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Haak HR, Hermans J, van de Velde CJ,
Lentjes EG, Goslings BM, Fleuren GJ and Krans HM: Optimal treatment
of adrenocortical carcinoma with mitotane: Results in a consecutive
series of 96 patients. Br J Cancer. 69:947–951. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Terzolo M, Angeli A, Fassnacht M, Daffara
F, Tauchmanova L, Conton PA, Rossetto R, Buci L, Sperone P,
Grossrubatscher E, et al: Adjuvant mitotane treatment for
adrenocortical carcinoma. N Engl J Med. 356:2372–2380. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Berruti A, Fassnacht M, Baudin E, Hammer
G, Haak H, Leboulleux S, Skogseid B, Allolio B and Terzolo M:
Adjuvant therapy in patients with adrenocortical carcinoma: A
position of an international panel. J Clin Oncol. 28:e401–e402.
2010. View Article : Google Scholar : PubMed/NCBI
|
